NCT06938191

Brief Summary

This study aimed to compare the changes in AQP -4, -5, -9, and IL-8 levels in pulp tissue, GCF, and dentin fluid samples routinely obtained during the treatment of healthy and symptomatic teeth diagnosed with irreversible pulpitis and investigate whether there is a correlation between them. A total of 70 patients aged 18-64 years with healthy (Group 1) and symptomatic irreversible pulpitis (Group 2) diagnosed at Kırıkkale University, Faculty of Dentistry, Department of Endodontics who will undergo routine root canal treatment will be included in the study, with a minimum of 35 participants for each group. Before starting treatment, DOS samples will be taken from healthy, symptomatic, irreversible pulpitis-diagnosed teeth and teeth contralateral to these teeth. A dentin fluid sample will be taken by holding the membrane on the dentin surface, and the pulp tissue will be removed and transferred to Eppendorf tubes. The treatment process will be completed by applying routine root canal procedures to the teeth. The samples' Aquaporin -4, -5, -9, and IL-8 levels will be analyzed by specific enzyme-linked immunosorbent assay (ELISA).

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
5mo left

Started Dec 2025

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress55%
Dec 2025Sep 2026

First Submitted

Initial submission to the registry

April 11, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 22, 2025

Completed
7 months until next milestone

Study Start

First participant enrolled

December 1, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 12, 2026

Expected
Last Updated

December 1, 2025

Status Verified

August 1, 2025

Enrollment Period

2 months

First QC Date

April 11, 2025

Last Update Submit

November 27, 2025

Conditions

Keywords

healthy pulppulpitisirreversible pulpitisaquaporin-4IL-8aquaporin-5aquaporin-9

Outcome Measures

Primary Outcomes (1)

  • Aquaporin-4, Aquaporin-5 and Aquaporin-9 expression levels in pulp tissue in dentin fluid and GCF samples

    Levels of IL-8, AQP-4, AQP-5 and AQP-9 will be measured in dentin fluid, GCF and pulp tissue samples obtained during routine root canal treatment. The analysis will be performed using ELISA. The aim is to compare the expression levels between healthy individuals and patients with irreversible pulpitis.

    Immediately after the procedure

Secondary Outcomes (1)

  • Correlation analysis between Aquaporin (AQP-4, AQP-5, AQP-9) and IL-8 levels in pulp tissue, dentin fluid, and GCF samples

    Immediately after the procedure

Study Arms (2)

healthy pulp group

Minimum 35 participants Procedure: Collection of GCF samples using periopaper. Collection of dentinal fluid using cellulose membrane. Collection of pulp tissue samples using a tirnerf.

irreversible pulp group

Minimum 35 participants Procedure: Collection of GCF samples using periopaper. Collection of dentinal fluid using cellulose membrane. Collection of pulp tissue samples using a tirnerf.

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

This study will include patients aged 18-64 years who present to the Department of Endodontics, Faculty of Dentistry, Kırıkkale University, with an indication for root canal therapy and are diagnosed with either a healthy pulp status (Group 1) or symptomatic irreversible pulpitis (Group 2).

You may qualify if:

  • Patients aged 18 to 64 years.
  • Patients without any known systemic disease.
  • Patients requiring root canal treatment for prosthetic purposes (Healthy pulp group).
  • Patients with third molars (wisdom teeth) indicated for extraction due to orthodontic or other clinical reasons (Healthy pulp group).
  • Patients diagnosed with symptomatic irreversible pulpitis based on the criteria established by the American Association of Endodontists (AAE) (Symptomatic irreversible pulpitis group).
  • Patients scheduled for routine root canal treatment at the Department of Endodontics, Faculty of Dentistry, Kırıkkale University.
  • Patients who have provided written informed consent to participate in the study.

You may not qualify if:

  • Patients with any known systemic disease.
  • Pregnant women or those suspected of being pregnant.
  • Patients who have used antibiotics, anti-inflammatory drugs, or antidepressants within the past 4 weeks.
  • Patients with significant dental plaque or calculus, gingival redness or bleeding, severe gingivitis, generalized periodontitis, or periodontal pockets deeper than 4 mm.
  • Patients with teeth showing internal or external root resorption.
  • Patients for whom complete rubber dam isolation cannot be achieved.
  • Patients with teeth exhibiting signs of necrosis, apical lesions, swelling, or presence of a sinus tract.
  • Patients with immature teeth presenting open apices.
  • Patients with third molars (wisdom teeth) that are not fully erupted or have been previously diagnosed with pericoronitis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pulpitis

Condition Hierarchy (Ancestors)

Dental Pulp DiseasesTooth DiseasesStomatognathic Diseases

Study Officials

  • TANSU M BEŞPARMAK, PhD student

    Kirikkale University, Faculty of Dentistry

    PRINCIPAL INVESTIGATOR
  • ALİ ERDEMİR, PROF

    Kirikkale University, Faculty of Dentistry

    STUDY CHAIR

Central Study Contacts

ALİ ERDEMİR, PROF.

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor doctor

Study Record Dates

First Submitted

April 11, 2025

First Posted

April 22, 2025

Study Start

December 1, 2025

Primary Completion

February 1, 2026

Study Completion (Estimated)

September 12, 2026

Last Updated

December 1, 2025

Record last verified: 2025-08